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EDITORIAL
Beyond a glomerulocentric view of inflammation
It has long been recognized that the kidney’s tubulo- ever, the lack of significant tubular in situ hybridization
interstitial space is affected during the course of glomeru- for M-CSF mRNA in some of these studies indicates
lar disease, and that the severity of this accompanying that antibody differences do not fully account for the
interstitial injury (inflammation, apoptosis, tubular atro- discrepancy.
phy, and fibrosis) influences the impact of a glomerulopa- M-CSF is a hematopoeitic growth factor that is impor-
thy on renal function. Release of pro-inflammatory fac- tant in the differentiation, survival, and proliferation of
tors from inflamed glomeruli into the interstitium has mature monocytes and macrophages [reviewed in 7].
been proposed as a pathogenic link between the glomer- M-CSF is also a regulatory cytokine that activates macro-
ular and interstitial compartments. Recent work, includ- phage cytokine production, enhances macrophage re-
ing the investigation presented by Isbel et al in this issue sponsiveness to secondary signals, and promotes chemo-
of Kidney International, suggest an alternative mecha- taxis [7]. Because glomerular M-CSF expression has been
nism—a more direct and perhaps independent role of the observed in both experimental and human GN [4–6], and
tubular epithelium in mediating the interstitial inflamma- correlates with renal macrophage accumulation, activa-
tion [1]. Tubular cells can be induced to express a number tion, and proliferation, as well as glomerular injury and
of immune modulators, some of which are listed in Table proteinuria [5, 6, 8, 9], a pro-inflammatory role for this
1. These tubule-derived factors must be considered when growth factor/cytokine has been assumed. Consistent with
designing therapies to control renal inflammation. such a role, the exogenous transfer of the M-CSF gene
Isbel et al provide evidence that renal tubular epithe- into kidneys of autoimmune MRL-Faslpr mice, but not
lium is a major site of production of macrophage colony- normal mice, causes local tissue injury accompanied by
stimulating factor (M-CSF) during experimental renal extensive macrophage infiltration [10]. However, while
injury [1]. Renal M-CSF expression was studied in rodent M-CSF is present in diseased kidneys, and can induce
models of anti-glomerular basement membrane (GBM) renal inflammation in appropriate settings, there is little
glomerulonephritis (GN), and unilateral ureteral obstruc- information regarding the impact of neutralizing M-CSF
tion, a tubulointerstitial process without glomerular in- on GN. In one study, congenital absence of M-CSF in the
volvement. The key finding of this study was the marked op/op mouse did not prevent induction of experimental
induction of M-CSF mRNA and protein expression in glomerular injury, although the GN model used appeared
the cortical tubules of the injured kidneys. Importantly, to be neutrophil- rather than macrophage-dependent
M-CSF was also found in nephritic glomeruli, but not [11]. In addition, the possibility of a beneficial effect of
glomeruli from obstructed kidneys. There was a correla- M-CSF expression during renal disease should not be
tion between tubular M-CSF, interstitial macrophage ac- overlooked. M-CSF is required in the neonatal period to
cumulation and proliferation, decline in creatinine clear- establish a normal renal macrophage population, which
ance, and proteinuria. M-CSF was also detected in urine may be involved in tissue remodeling [12]. Furthermore,
after renal injury. Consistent with tubular M-CSF pro- some studies have shown that an increase in tissue M-CSF
duction, human tubular epithelial cells have been shown is later followed by an influx of macrophages with immu-
to release M-CSF in vitro [2], and, in a mouse model of nosuppressive activity [7]. Thus, the expression of M-CSF
ischemia-reperfusion injury, where the prominent lesion during renal disease may be important for resolution of
is tubular, not glomerular, M-CSF mRNA (whole kid- inflammation and remodeling of injured tissue. The net
ney) was rapidly up-regulated [3]. It should be pointed effect of M-CSF may depend on when it is expressed in
out, however, that most studies to date have found tubu- the course of renal disease, the presence of other cyto-
lar M-CSF to be much lower, or negligible, compared kines, and the genetic background of affected individuals.
to glomerular M-CSF, at least in the context of GN [4–6]. While the role of M-CSF in renal inflammation remains
Isbel et al suggest that this discrepancy may be due to to be completely characterized, it is clear from the work
differences in the antibodies used to detect M-CSF. How- of Isbel et al and others that tubular cells can produce
immune modulators in vivo, in the absence of GN. An
important question is whether attenuation of tubular cyto-Key words: macrophage colony-stimulating factor, tubulointerstitial
injury, tubular epithelium, glomerulonephritis. kine production ameliorates renal disease during GN.
Recent data address this issue. Tesch et al demonstrated 2001 by the International Society of Nephrology
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Table 1. Immune mediators made by renal tubular cells glomerulus, it is intriguing to speculate whether the epi-
thelium could become autonomous and maintain pro-Complement components C3, C4
Chemokines MCP-1, IL-8, RANTES, IP-10 duction of inflammatory and profibrotic factors after res-
Cytokines IL-6, TNF-, IFN- olution of GN, leading to progressive renal impairment.Growth factors GM-CSF, M-CSF, PDGF, TGF-, VEGF
Understanding these mechanisms should be a high prior-
Abbreviations are: MCP-1, monocyte chemoattractant protein-1; IL-8, inter-
ity in future investigations.leukin-8; RANTES, regulated upon activation, normal T cell expressed and
secreted; IP-10, gamma interferon-inducible protein-10; IL-6, interleukin-6;
TNF-, tumor necrosis factor-alpha; IFN-, interferon gamma; GM-CSF, granu- Brad H. Rovinlocyte macrophage colony-stimulating factor; M-CSF, macrophage colony-stimu-
Columbus, Ohiolating factor; PDGF, platelet-derived growth factor; TGF-, transforming growth
factor-beta; VEGF, vascular endothelial growth factor.
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